Hims & Hers pulls copycat weight-loss pill after legal threats

Hims & Hers pulls copycat weight-loss pill after legal threats

Piotr Swat | Lightrocket | Getty Images Hims & Hers on Saturday said that it will pull its copycat weight-loss pill off the market after sparking controversy and threats of legal action earlier this week. “Since launching the compounded semaglutide pill on our platform, we’ve had constructive conversations with stakeholders across the industry,” the telehealth…

Read More
Private credit’s ‘off-ramp’ emerges as investors look to cash out

Private credit’s ‘off-ramp’ emerges as investors look to cash out

Key Points Semi-liquid private credit vehicles have curbed withdrawals as investors scramble to withdraw their money. A “robust and growing” secondaries market could help ease pressure amid concerns over squeezed liquidity. Private credit investors may have a potential “off-ramp” as pressure to cash out of the $3 trillion industry grows. Asset managers in the sector,…

Read More